RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Collplant Biotechnologies P/S 2024

Collplant Biotechnologies P/S

24.82

Collplant Biotechnologies Dividend yield

Ticker

CLGN

ISIN

US19516R1077

WKN

A2PMPX

As of May 24, 2024, Collplant Biotechnologies's P/S ratio stood at 24.82, a 212.99% change from the 7.93 P/S ratio recorded in the previous year.

The Collplant Biotechnologies P/S history

Collplant Biotechnologies Aktienanalyse

What does Collplant Biotechnologies do?

CollPlant Biotechnologies Ltd is a biotechnology company specializing in the development and production of collagen-based products. The company was founded in 2004 and is headquartered in Rehovot, Israel. The company's history is rooted in collagen research. Collagen is an important component of connective tissue, providing structure and strength. The company specializes in the use of plant-based collagen derived from a specific plant called Nicotiana tabacum. Plant-based collagen has the advantage of being biocompatible, biodegradable, and more cost-effective than animal-based collagen. CollPlant Biotechnologies' business model is to develop and sell collagen-based products for various industries. The company's main sectors are medicine, cosmetics, and 3D printing. Each sector offers its own products and has different requirements for collagen. In the medicine sector, CollPlant Biotechnologies offers collagen-based products for wound healing, bone regeneration, and treatment of skin diseases. The advantage of plant-based collagen is that it causes very few allergic reactions and is well tolerated. In the cosmetics sector, the company develops collagen-based products for skincare, particularly for reducing wrinkles and fine lines. CollPlant Biotechnologies also has its own cosmetics brand called "Verifeel," which offers collagen-based creams and serums. The 3D printing sector is a relatively new initiative for the company. Here, CollPlant Biotechnologies develops collagen-based materials that can be used for 3D printing of biological tissues and organs. The advantage of plant-based collagen in 3D printing is that it is highly moldable and biocompatible. CollPlant Biotechnologies also has a partnership with one of the world's largest tobacco companies, Philip Morris International. Together, they are working to produce plant-based collagen on an industrial scale. Overall, CollPlant Biotechnologies has a promising future. The company has specialized in a unique niche in the biotechnology sector and offers a variety of products for different industries. With the partnership with Philip Morris International and the development of 3D printing materials, the company also has other exciting opportunities for the future. Collplant Biotechnologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Collplant Biotechnologies's P/S Ratio

Collplant Biotechnologies's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Collplant Biotechnologies's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Collplant Biotechnologies's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Collplant Biotechnologies’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Collplant Biotechnologies Stock

What is the price-to-earnings ratio of Collplant Biotechnologies?

The price-earnings ratio of Collplant Biotechnologies is currently 24.82.

How has the price-earnings ratio of Collplant Biotechnologies changed compared to last year?

The price-to-earnings ratio of Collplant Biotechnologies has increased by 212.99% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Collplant Biotechnologies high compared to other companies?

Yes, the price-to-earnings ratio of Collplant Biotechnologies is high compared to other companies.

How does an increase in the price-earnings ratio of Collplant Biotechnologies affect the company?

An increase in the price-earnings ratio of Collplant Biotechnologies would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Collplant Biotechnologies affect the company?

A decrease in the price-earnings ratio of Collplant Biotechnologies would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Collplant Biotechnologies?

Some factors that influence the price-earnings ratio of Collplant Biotechnologies are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Collplant Biotechnologies pay?

Over the past 12 months, Collplant Biotechnologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Collplant Biotechnologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Collplant Biotechnologies?

The current dividend yield of Collplant Biotechnologies is .

When does Collplant Biotechnologies pay dividends?

Collplant Biotechnologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Collplant Biotechnologies?

Collplant Biotechnologies paid dividends every year for the past 0 years.

What is the dividend of Collplant Biotechnologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Collplant Biotechnologies located?

Collplant Biotechnologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Collplant Biotechnologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Collplant Biotechnologies from 5/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/24/2024.

When did Collplant Biotechnologies pay the last dividend?

The last dividend was paid out on 5/24/2024.

What was the dividend of Collplant Biotechnologies in the year 2023?

In the year 2023, Collplant Biotechnologies distributed 0 USD as dividends.

In which currency does Collplant Biotechnologies pay out the dividend?

The dividends of Collplant Biotechnologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Collplant Biotechnologies

Our stock analysis for Collplant Biotechnologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Collplant Biotechnologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.